Catherine Uyttenhove

Person

Brussels, BE

People

Patents Grantslast 30 patents

Information Patent Grant
TGF-β1 specific antibodies and methods and uses thereof
- Patent number 11,957,751
- Issue date Apr 16, 2024
- Ludwig Institute for Cancer Research, Ltd.
- Jacques Van Snick
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Grant
TGF-β3 specific antibodies and methods and uses thereof
- Patent number 11,485,780
- Issue date Nov 1, 2022
- Ludwig Institute for Cancer Research, Ltd.
- Jacques Van Snick
- G01 - MEASURING TESTING
Information Patent Grant
TGF-ß1 specific antibodies and methods and uses thereof
- Patent number 10,947,303
- Issue date Mar 16, 2021
- Ludwig Institute for Cancer Research, Ltd.
- Jacques Van Snick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGF-β3 specific antibodies and methods and uses thereof
- Patent number 10,723,793
- Issue date Jul 28, 2020
- Ludwig Institute for Cancer Research, Ltd.
- Jacques Van Snick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TGF-β1 specific antibodies and methods and uses thereof
- Patent number 10,035,851
- Issue date Jul 31, 2018
- Ludwig Institute for Cancer Research Ltd.
- Jacques Van Snick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TGF-β1 specific antibodies and methods and uses thereof
- Patent number 9,518,112
- Issue date Dec 13, 2016
- Ludwig Institute for Cancer Research Ltd.
- Jacques Van Snick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant anti-interleukin-9 antibodies
- Patent number 7,371,383
- Issue date May 13, 2008
- MedImmune, Inc.
- Jennifer Lynne Reed
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Adjuvant compositions for vaccines
- Patent number 6,375,945
- Issue date Apr 23, 2002
- SmithKline Beecham Biologicals s.a.
- Thierry Boon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for preparing mammalian T cell growth factor P40
- Patent number 5,750,377
- Issue date May 12, 1998
- Ludwig Institute for Cancer Research
- Jacques Van Snick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
T cell growth factor
- Patent number 5,587,302
- Issue date Dec 24, 1996
- Ludwig Institute for Cancer Research
- Jacques Van Snick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for inhibiting production of IgE by using IL-9 inhibitors
- Patent number 5,246,701
- Issue date Sep 21, 1993
- Ludwig Institute for Cancer Research
- Bernard Dugas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
T cell growth factor glycoproteins
- Patent number 5,208,218
- Issue date May 4, 1993
- Ludwig Institute for Cancer Research
- Jacques Van Snick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Uses of substantially pure interleukin-9 receptor
- Patent number 5,180,678
- Issue date Jan 19, 1993
- Ludwig Institute for Cancer Research
- Catherine Druez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for enhanced growth and proliferation of mast cells
- Patent number 5,164,317
- Issue date Nov 17, 1992
- Ludwig Institute for Cancer Research
- Lothar Hultner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies immunoreactive with the T-cell growth factor, P40
- Patent number 5,157,112
- Issue date Oct 20, 1992
- Ludwig Institute for Cancer Research
- Jacques Van Snick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for inhibiting production of IGE and method for enhancing pr...
- Patent number 5,132,109
- Issue date Jul 21, 1992
- Ludwig Institute for Cancer Research
- Bernard Dugas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substantially pure interleukin-9 receptor and uses thereof
- Patent number 5,116,951
- Issue date May 26, 1992
- Ludwig Institute for Cancer Research
- Catherine Druez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TGF-BETA 3 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF
- Publication number 20230287094
- Publication date Sep 14, 2023
- LUDWIG INSTITUTE FOR CANCER RESEARCH, LTD.
- Jacques VAN SNICK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGF-B1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF
- Publication number 20210403545
- Publication date Dec 30, 2021
- Ludwig Institute for Cancer Research Ltd.
- Jacques Van Snick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGF-BETA 3 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF
- Publication number 20200392221
- Publication date Dec 17, 2020
- LUDWIG INSTITUTE FOR CANCER RESEARCH, LTD.
- Jacques VAN SNICK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF-ß1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF
- Publication number 20190092847
- Publication date Mar 28, 2019
- Ludwig Institute for Cancer Research Ltd.
- Jacques Van Snick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF-BETA 3 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF
- Publication number 20180148501
- Publication date May 31, 2018
- Ludwig Institute for Cancer Research Ltd.
- Jacques VAN SNICK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGF-ß1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF
- Publication number 20170137507
- Publication date May 18, 2017
- Jacques Van Snick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGF-BETA1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF
- Publication number 20150132319
- Publication date May 14, 2015
- Jacques Van Snick
- G01 - MEASURING TESTING
Information Patent Application
Recombinant Anti-Interleukin-9 Antibodies
- Publication number 20080299134
- Publication date Dec 4, 2008
- MedImmune, Inc.
- Jennifer Lynne Reed
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases
- Publication number 20070048261
- Publication date Mar 1, 2007
- GlaxoSmithKline Biologicals S.A.
- Pascal Mettens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADJUVANT COMPOSITIONS FOR VACCINES
- Publication number 20020160011
- Publication date Oct 31, 2002
- THIERRY BOON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Catherine Uyttenhove

Person

Patents Grantslast 30 patents

TGF-β1 specific antibodies and methods and uses thereof

TGF-β3 specific antibodies and methods and uses thereof

TGF-ß1 specific antibodies and methods and uses thereof

TGF-β3 specific antibodies and methods and uses thereof

TGF-β1 specific antibodies and methods and uses thereof

TGF-β1 specific antibodies and methods and uses thereof

Recombinant anti-interleukin-9 antibodies

Adjuvant compositions for vaccines

Process for preparing mammalian T cell growth factor P40

T cell growth factor

Method for inhibiting production of IgE by using IL-9 inhibitors

T cell growth factor glycoproteins

Uses of substantially pure interleukin-9 receptor

Method for enhanced growth and proliferation of mast cells

Antibodies immunoreactive with the T-cell growth factor, P40

Method for inhibiting production of IGE and method for enhancing pr...

Substantially pure interleukin-9 receptor and uses thereof

Patents Applicationslast 30 patents

TGF-BETA 3 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF

TGF-B1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF

TGF-BETA 3 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF

TGF-ß1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF

TGF-BETA 3 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF

TGF-ß1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF

TGF-BETA1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF

Recombinant Anti-Interleukin-9 Antibodies

Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases

ADJUVANT COMPOSITIONS FOR VACCINES